154 related articles for article (PubMed ID: 31903164)
1. IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells.
Tang Z; Gillatt D; Rowe E; Koupparis A; Holly JMP; Perks CM
Oncotarget; 2019 Dec; 10(66):7043-7057. PubMed ID: 31903164
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells.
Zeng L; Jarrett C; Brown K; Gillespie KM; Holly JM; Perks CM
Exp Cell Res; 2013 Aug; 319(14):2282-95. PubMed ID: 23810988
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
4. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
5. [Expression of IκBα in bladder cancer cell lines is negatively correlated with epithelial-mesenchymal transition and cell invasion in vitro].
Wang X; Cheng H; Chen Y; Li H; He D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Nov; 30(11):1159-61. PubMed ID: 25374080
[TBL] [Abstract][Full Text] [Related]
6. GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process.
Shen J; Lv X; Zhang L
Onco Targets Ther; 2020; 13():2511-2522. PubMed ID: 32280236
[TBL] [Abstract][Full Text] [Related]
7. Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells.
Aparicio LA; Castosa R; Haz-Conde M; Rodríguez M; Blanco M; Valladares M; Figueroa A
BMC Cancer; 2014 Jul; 14():507. PubMed ID: 25012153
[TBL] [Abstract][Full Text] [Related]
8. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway.
Yang HJ; Liu GL; Liu B; Liu T
J Cell Mol Med; 2018 Mar; 22(3):1650-1665. PubMed ID: 29349903
[TBL] [Abstract][Full Text] [Related]
9. The Role of TKS5 in Chromosome Stability and Bladder Cancer Progression.
Wang W; Zheng X; Azoitei A; John A; Zengerling F; Wezel F; Bolenz C; Günes C
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430759
[TBL] [Abstract][Full Text] [Related]
10. Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
Yang X; Shi L; Yi C; Yang Y; Chang L; Song D
Int J Urol; 2018 Feb; 25(2):157-163. PubMed ID: 29117631
[TBL] [Abstract][Full Text] [Related]
11. YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition.
Hao H; Chen H; Xie L; Liu H
Ann Med; 2021 Dec; 53(1):1170-1178. PubMed ID: 34259106
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
13. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
14. ALDOLASE A regulates invasion of bladder cancer cells via E-cadherin-EGFR signaling.
Li J; Wang F; Gao H; Huang S; Cai F; Sun J
J Cell Biochem; 2019 Aug; 120(8):13694-13705. PubMed ID: 31081974
[TBL] [Abstract][Full Text] [Related]
15. Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity.
Wahlin S; Boman K; Moran B; Nodin B; Gallagher WM; Karnevi E; Jirström K
BMC Cancer; 2022 Feb; 22(1):131. PubMed ID: 35109796
[TBL] [Abstract][Full Text] [Related]
16. Possible correlation of sonic hedgehog signaling with epithelial-mesenchymal transition in muscle-invasive bladder cancer progression.
Kitagawa K; Shigemura K; Sung SY; Chen KC; Huang CC; Chiang YT; Liu MC; Huang TW; Yamamichi F; Shirakawa T; Fujisawa M
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2261-2271. PubMed ID: 31367836
[TBL] [Abstract][Full Text] [Related]
17. Short interfering RNA directed against Slug blocks tumor growth, metastasis formation, and vascular leakage in bladder cancer.
Wang X; Zhang K; Sun L; Liu J; Lu H
Med Oncol; 2011 Dec; 28 Suppl 1():S413-22. PubMed ID: 21053100
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines.
Adhim Z; Matsuoka T; Bito T; Shigemura K; Lee KM; Kawabata M; Fujisawa M; Nibu K; Shirakawa T
Br J Cancer; 2011 Jul; 105(3):393-402. PubMed ID: 21750550
[TBL] [Abstract][Full Text] [Related]
19. CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways.
Ruan H; Li Y; Wang X; Sun B; Fang W; Jiang S; Liang C
Jpn J Clin Oncol; 2020 Mar; 50(3):254-260. PubMed ID: 31829429
[TBL] [Abstract][Full Text] [Related]
20. Yes-associated protein 1 promotes bladder cancer invasion by regulating epithelial-mesenchymal transition.
Chen X; Li S; Yu Z; Tan W
Int J Clin Exp Pathol; 2019; 12(3):1070-1077. PubMed ID: 31933921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
